Microbot Medical's LIBERTY System adopted by first Pennsylvania academic center; now in 7 states

Microbot Medical Inc.

Globally recognized academic center in Pennsylvania is first in state to adopt LIBERTY Endovascular Robotic System.
Company now has accounts in seven Eastern U.S. states, with multiple hospitals across health systems.
Full market release in Q2 2026; plans to expand sales territory to the West Coast.
Recent agreement to expand access to LIBERTY System across U.S. federal healthcare systems, including veterans and military.
CEO cites continued customer adoption and confidence in commercialization strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.